Dr. Mohammad Meshkini PhD (Iran University of Medical Sciences); Fellowship (Shahid Beheshti University of Medical Sciences); Health-MBA (Shahid Beheshti University of Medical Sciences); Evidence Implementation Training Program (JBI); MD-PG (Iran University of Medical Sciences
Tabriz University of Medical Sciences, Tabriz, East Azerbaijan · Iran
Editorial leadership for International Journal of Coronaviruses ISSN 2692-1537
Research interests
- Molecular Oncology Cancer Cell Signaling (Pi3K/Akt/Mtor
- Wnt) Hepatocellular Carcinoma (Liver Cancer) Breast Cancer Apoptosis
- Cell Proliferation Molecular Mechanisms Of Cancer Cancer Drug Discovery Gene Expression Regulation
Biography
Dr. Mohammad Meshkini is a dedicated researcher and Associate Professor in the Department of Molecular Medicine at Tabriz University of Medical Sciences. His research is centered on elucidating the complex molecular mechanisms that drive cancer development, with a particular emphasis on hepatocellular carcinoma (liver cancer). Dr. Meshkini investigates key cellular signaling pathways, such as PI3K/AKT/mTOR, and their role in cancer cell proliferation, apoptosis, and metastasis. He also explores the potential of various natural and synthetic compounds as therapeutic agents to target these pathways and inhibit cancer growth. His work combines molecular biology, cell culture, and animal models to translate fundamental discoveries into potential clinical applications. Dr. Meshkini has a strong publication record and is actively involved in mentoring graduate students, contributing to the advancement of cancer research.
Education Details:
- PhD in Molecular Medicine, Tarbiat Modares University, Tehran, Iran (2014)
- MSc in Clinical Biochemistry, Tabriz University of Medical Sciences, Tabriz, Iran (2007)
- BSc in Laboratory Sciences, Tabriz University of Medical Sciences, Tabriz, Iran (2004)
Professional Background:
- Associate Professor, Department of Molecular Medicine, Tabriz University of Medical Sciences, Iran (Present)
- Head of Department, Department of Molecular Medicine, Tabriz University of Medical Sciences, Iran
Achievements:
- Recipient of various institutional and national research grants for work on cancer signaling pathways.
- Serves as Head of the Department of Molecular Medicine at the Faculty of Advanced Medical Sciences.
Current Research Projects
His current research focuses on the crosstalk between major signaling pathways (e.g., Wnt/β-catenin and PI3K/AKT) in liver cancer and their role in chemoresistance. He is also actively evaluating the anticancer effects of specific microRNAs and novel drug formulations, including nanoliposomal delivery systems for natural compounds.
Academic Profiles of Dr. Mohammad Meshkini
Selected publications
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJCV for your work?
This journal is guided by Dr. Mohammad Meshkini (Tabriz University of Medical Sciences, Tabriz, East Azerbaijan) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.